BioSpace News Archive

Policy

Amgen, J&J Settle Patent Dispute Over Stelara Biosimilar

While the exact settlement details are confidential, the deal will allow Amgen to launch its Stelara biosimilar no later than January 1, 2025.

May 24, 2023
·
2 min read
·
Tristan Manalac
Drug Development

PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop

Despite a disappointing showing in the Phase III MOVE-FA trial, PTC Therapeutics says it will move forward with regulatory talks for the Friedreich’s ataxia treatment. Meanwhile, the company is discontinuing several early-stage gene therapies and reducing its headcount.

May 24, 2023
·
2 min read
·
Tristan Manalac
Amyloid-Beta Structure Revelation Sheds Light on Leqembi’s Function

Researchers elucidate the component structure of Alzheimer’s-associated plaques, shedding light on anti-amyloid antibodies’ mechanism of action.

May 24, 2023
·
3 min read
·
Heather McKenzie
Business

ElevateBio Takes Title of Largest 2023 Funding with $401M Series D

The Massachusetts-based company has claimed the year’s largest fundraise so far and secured a powerhouse R&D partner in Novo Nordisk to develop gene editing medicines.

May 24, 2023
·
2 min read
·
Tristan Manalac
FDA

FDA Approves Innoviva’s Bacterial Pneumonia Treatment

The regulator approved Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia. The NDA was filed by Entasis Therapeutics, which Innoviva acquired in 2022.

May 24, 2023
·
2 min read
·
Kate Goodwin
Drug Development

Wave’s Antisense ALS Therapy Is Company’s Latest Miss

Wave will discontinue development of WVE-004 in C9-associated ALS and frontotemporal dementia after the therapy failed to show any clinical benefit in a mid-stage trial.

May 24, 2023
·
3 min read
·
Heather McKenzie
Employer Resources

What People with Autism Wish Their Employers Knew

Autistic employees bring a uniquely valuable skill set to the life sciences workplace, but it’s on the employers to provide the support they need.

May 24, 2023
·
5 min read
·
Rosemary Scott
XNK Therapeutics to present at ABG Sundal Collier’s Life Science Summit in Stockholm

XNK Therapeutics announced that its CEO Johan Liwing will present at ABG Sundal Collier’s Life Science Summit in Stockholm, Sweden, on May 31 at 10:00am CEST.

May 24, 2023
·
1 min read
Biotech Bay

Lighthouse Pharmaceuticals Announces Presentation at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Lighthouse Pharmaceuticals, a clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s and other degenerative diseases, announced the upcoming presentation of new data and strategic plans in a Plenary Presentation during the Pharmaceutical Pipeline session.

May 24, 2023
·
2 min read
BioMidwest

Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability

Artelon Inc., a privately held medical device company, announced that it closed approximately $20 million in Series B funding, led by Vensana Capital with expected additional participation from existing investors.

May 24, 2023
·
3 min read